バイアスGタンパク質βγサブユニットの下流信号は,ニトログリセリン誘発の熱過敏症の間,内生オピオイド受容体アゴニストの鎮痛効果を高めます

Farzanna A Mohamed¹, Alan V Smrcka¹, Emily M Jutkiewicz¹

¹Department of Pharmacology, University of Michigan, Ann Arbor, Michigan.

Molecular pharmacology

|September 6, 2025

まとめ

ガレインはGβγシグナル伝達阻害剤であり,オピオイドによる疼痛緩和を増加させず,持続的な痛みの管理とオピオイド使用障害のリスクを減らすためのより安全な戦略を提供します.

科学分野:

神経科学
薬理学について
痛みの管理

背景:

μ- オピオイド受容体 (MOR) アゴニストは急性疼痛緩和に不可欠ですが,副作用とオピオイド使用障害のリスクがあります.
これらのリスクを軽減するためにより安全なオピオイド鎮痛剤の開発が不可欠です

研究の目的:

持続的な痛みの管理におけるGβγシグナル伝達阻害体であるガレインの有効性を調査する.
ガレインがモルヒンの鎮痛効果を強めるか評価する

主な方法:

ネズミでニトログリセリン (NTG) 誘発熱過敏症モデルを使用した.
ウォーターテール・リトラクション・アッセイを用いて痛みの反応を評価した.
モルヒネと併用してガレインを投与し,ナロキソン前治療の効果を評価した.

主要な成果:

ガレインは単独でNTG誘発の過敏症を完全に逆転させました.
低用量で効果のないガレインはモルフィンの抗過敏効果を強めた.
ナロキソンはガレインの抗痛薬効果とモルフィンの強化を阻害した.
NTG誘発の過敏症は,PLCβ3ノックアウトマウスでは存在せず,PLCβ3が疼痛シグナル伝達に作用することを示唆した.

結論:

ガレインは内因的なオピオイド受容体の活性化によって介される抗痛薬効果を発揮する.
MORの活性化後のGβγシグナル伝達を阻害すると,鎮痛効果が向上する.
このアプローチは,より安全な痛み管理とオピオイド使用障害を減らすための有望な戦略です.

キーワード:

アンチノシセプション Gタンパク質ガレイン過剰感受性オピオイド受容体フォスフォリファースC

さらに関連する動画

09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

607

07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.4K

関連する概念動画

01:25

Analgesia and Pain Management

788

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

788

01:28

Nitric Oxide Signaling Pathway

5.2K

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...

5.2K

01:12

GPCR Desensitization

6.4K

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

6.4K

01:09

GPCRs Regulate Adenylyl Cylase Activity

5.9K

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

5.9K

01:16

Antianginal Drugs: Nitrates and β-Blockers

744

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

744

01:22

Opioid Receptors: Overview

1.8K

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...